ClinicalTrials.Veeva

Menu

Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction (CAPRI)

Yonsei University logo

Yonsei University

Status

Completed

Conditions

ST-segment Elevation Myocardial Infarction

Treatments

Procedure: PPCI plus RIPC
Procedure: PPCI only

Study type

Interventional

Funder types

Other

Identifiers

NCT02164695
CR314003

Details and patient eligibility

About

To evaluate whether remote ischemic per-conditioning (RIPC) can reduce infarct size in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (PPCI) within 12 hours of symptoms onset.

  • Control group: PPCI only
  • Study group: PPCI + RIPC

Primary endpoint: Infarct size measured by contrast-enhanced cardiac magnetic resonance (CMR) at 6 months after the index procedure

Full description

ST-elevation myocardial infarction (STEMI) is a leading cause of mortality and morbidity. Early myocardial reperfusion with either of thrombolytic therapy or primary percutaneous coronary intervention (PPCI) is the most effective strategy for reducing the size of a myocardial infarct and improving the clinical outcome. Although this process can restore blood flow to the ischemic myocardium, it can induce injury. This phenomenon termed myocardial reperfusion injury can paradoxically reduce the beneficial effects of myocardial reperfusion. The pre-clinical study in animal models of acute myocardial infarction suggests that lethal reperfusion injury accounts for up to 50% of the final size of a myocardial infarct.

Remote ischemic conditioning uses brief ischemia and reperfusion of a distant organ to protect the myocardium. In animal study, remote ischemic postconditioning seems to be more effective than local postconditioning in experimental myocardial infarction.Bøtker et al. has reported remote ischemic preconditioning before hospital admission increase myocardial salvage in patients with acute myocardial infarction.

The objective of this study is to evaluate whether remote ischemic per-conditioning (RIPC) can reduce late infarct size in patients with STEMI treated with PPCI within 12 hours of symptoms onset. To test this hypothesis, we will randomize patients into PPCI + RIPC or PPCI alone. We will evaluate marker of reperfusion injury using contrast cardiac magnetic resonance image.

Enrollment

118 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >19 years
  • Presenting within 12 hours of symptom onset
  • >20 min of chest pain
  • ST-elevation myocardial infarction defined as ST-segment elevation (>0.1 mV) in at least 2 contiguous precordial leads

Exclusion criteria

  • Previous myocardial infarction
  • Presence of chronic total occlusion
  • Evidence of retrograde filling by collaterals at coronary angiography (Rentrop 2 or 3 collateral flow)
  • Severe multi-vessel coronary artery disease to require further interventions before follow-up CMR
  • Cardiac arrest before randomization
  • Arrhythmias requiring external electric shock before randomization
  • Unwillingness to participate
  • External electric shock for cardioversion within first 3 days
  • Cardiac surgery within first 3 days

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

118 participants in 2 patient groups

PPCI plus RIPC
Active Comparator group
Description:
The patients randomized to PPCI plus RIPC group will receive RIPC during PPCI.
Treatment:
Procedure: PPCI plus RIPC
PPCI only
Sham Comparator group
Description:
The patients randomized to PPCI only group will receive PPCI only but the sham procedure of RIPC.
Treatment:
Procedure: PPCI only

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems